<b>Wilson Sonsini, Cooley take Conkwest public</b>
<p/>
Clinical-stage immunotherapy company Conkwest Inc. is relying on Wilson Sonsini Goodrich
& Rosati PC in connection with its proposed initial public offering. Share volume
and pricing details have not been disclo...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In